Antiphospholipid antibodies and malignancy.
Antiphospholipid antibody syndrome is characterized clinically by venous or arterial thrombosis, recurrent fetal loss, or placental insufficiency in women. This article describes the prevalence of malignancy, the manifestations, and the prognosis for this condition.
Pham
Chi
C
The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390-8852, USA.
Shen
Yu-Min
YM
D017152:Antibodies, Antiphospholipid; D016736:Antiphospholipid Syndrome / Q000150:complications*; D006801:Humans; D009369:Neoplasms / Q000097:blood / Q000150:complications* / Q000276:immunology*; D012307:Risk Factors; D019851:Thrombophilia / Q000150:complications / Q000276:immunology; D013927:Thrombosis / Q000150:complications
D017152:Antibodies, Antiphospholipid